USA |NASDAQ |USD
Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
---|---|---|---|---|
Sep 26, 2022 | Jun 2022 | - | - | $-0.81 |
Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
---|---|---|---|---|
Sep 26, 2022 | Jun 2022 | - | - | $23.48M |
Aytu Bioscience's next earnings date is Monday, Sep 26, 2022 for the fiscal quarter ending Jun 2022.
Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
---|
Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
---|---|---|---|---|
Jun 2022 | 1 | $-1.70 | $-1.70 | $-1.70 |
Jun 2023 | 1 | $-1.07 | $-1.07 | $-1.07 |
Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
---|
Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
---|---|---|---|---|
Jun 2022 | 0 / 0 | $-0.96 | $-0.55 | $-0.55 |
Jun 2023 | 1 / 0 | $-0.31 | $1.06 | $1.06 |
Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
---|
Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
---|---|---|---|---|
Jun 2022 | 1 | $106.80M | $106.80M | $106.80M |
Jun 2023 | 1 | $118.50M | $118.50M | $118.50M |
Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
---|---|---|---|---|
May 16, 2022 | Mar 2022 | $-0.41 | - | - |
Feb 14, 2022 | Dec 2021 | $-0.58 | $-0.44 | 24.14% |
Nov 15, 2021 | Sep 2021 | $-0.29 | $-1.09 | -282.46% |
Sep 27, 2021 | Jun 2021 | $-0.41 | $-0.81 | -97.56% |
May 17, 2021 | Mar 2021 | $-0.33 | $-1.41 | -323.04% |
Feb 11, 2021 | Dec 2020 | $-0.44 | $-0.72 | -63.64% |
Oct 6, 2020 | Sep 2020 | $-0.35 | $-0.30 | 14.29% |
Sep 24, 2020 | Jun 2020 | $-0.35 | $-0.20 | 42.86% |
May 15, 2020 | Mar 2020 | $-0.50 | $-1.50 | -200.00% |
Feb 14, 2020 | Dec 2019 | $-1.70 | $-0.10 | 94.12% |
Nov 14, 2019 | Sep 2019 | $-2.75 | $-3.20 | -16.36% |
Sep 26, 2019 | Jun 2019 | $-3.30 | $-13.00 | -293.94% |
May 14, 2019 | Mar 2019 | $-5.80 | $-5.00 | 13.79% |
Feb 7, 2019 | Dec 2018 | $-3.95 | $-7.20 | -82.28% |
Nov 7, 2018 | Sep 2018 | $-14.50 | $-19.60 | -35.17% |
Sep 6, 2018 | Jun 2018 | - | $0.31 | - |
May 14, 2018 | Mar 2018 | $-200.00 | $-48.00 | 76.00% |
Feb 8, 2018 | Dec 2017 | $-356.00 | $-178.00 | 50.00% |
Nov 9, 2017 | Sep 2017 | $-404.00 | $-352.00 | 12.87% |
Aug 31, 2017 | Jun 2017 | $-1720.00 | $-1340.00 | 22.09% |
May 11, 2017 | Mar 2017 | $-1506.67 | $-1920.00 | -27.43% |
Feb 9, 2017 | Dec 2016 | $-1733.33 | $-2440.00 | -40.77% |
Nov 7, 2016 | Sep 2016 | $-2360.00 | $-4680.00 | -98.31% |
Sep 1, 2016 | Jun 2016 | $-3120.00 | $-9092.00 | -191.41% |
May 4, 2016 | Mar 2016 | - | $-1854.38 | - |
Dec 31, 2015 | Dec 2015 | - | $-11217.23 | - |
Sep 30, 2015 | Sep 2015 | - | $-7661.95 | - |
Mar 31, 2015 | Mar 2015 | - | $-24108.10 | - |
Feb 28, 2015 | Dec 2014 | - | $-988.87 | - |
Nov 30, 2014 | Sep 2014 | - | $-1599.89 | - |
Aug 31, 2014 | Jun 2014 | - | $-1140.71 | - |
May 31, 2014 | Mar 2014 | - | $-1350.18 | - |
Feb 28, 2014 | Dec 2013 | - | $-2637.63 | - |
Nov 30, 2013 | Sep 2013 | - | $-1961.85 | - |
Aug 31, 2013 | Jun 2013 | - | $-1260.46 | - |
May 31, 2013 | Mar 2013 | - | $-1585.35 | - |
Feb 28, 2013 | Dec 2012 | - | $-1632.44 | - |
Nov 30, 2012 | Sep 2012 | - | $-2385.94 | - |
Aug 31, 2012 | Jun 2012 | - | $-2184.62 | - |
May 31, 2012 | Mar 2012 | - | $-1442.35 | - |
Feb 29, 2012 | Dec 2011 | - | $-1229.77 | - |
Nov 30, 2011 | Sep 2011 | - | $-2413.06 | - |
Aug 31, 2011 | Jun 2011 | - | $-10247.12 | - |
May 31, 2011 | Mar 2011 | - | $-2871.48 | - |
Feb 28, 2011 | Dec 2010 | - | $-3825.84 | - |
Nov 30, 2010 | Sep 2010 | - | $-2966.23 | - |
Aug 31, 2010 | Jun 2010 | - | $-2356.07 | - |
May 31, 2010 | Mar 2010 | - | $-2495.40 | - |
Feb 28, 2010 | Dec 2009 | - | $-2058.53 | - |
Nov 30, 2009 | Sep 2009 | - | $-3211.20 | - |
Aug 31, 2009 | Jun 2009 | - | $-1926.12 | - |
May 31, 2009 | Mar 2009 | - | $-1633.78 | - |
Feb 28, 2009 | Dec 2008 | - | $-2738.65 | - |
Nov 30, 2008 | Sep 2008 | - | $-3833.03 | - |
Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
---|---|---|---|---|
Sep 27, 2021 | Jun 2021 | $-2.44 | $-3.24 | - |
Sep 24, 2020 | Jun 2020 | $-0.22 | $-5.00 | - |
Sep 26, 2019 | Jun 2019 | $-2.20 | $-44.80 | - |
Sep 6, 2018 | Jun 2018 | $0.00 | $-577.69 | - |
Aug 31, 2017 | Jun 2017 | - | $-10380.00 | - |
Sep 1, 2016 | Jun 2016 | - | $-56522.42 | - |
Aug 31, 2014 | Jun 2014 | - | $-7090.37 | - |
Aug 31, 2013 | Jun 2013 | - | $-6864.20 | - |
Aug 31, 2012 | Jun 2012 | - | $-7269.81 | - |
Aug 31, 2011 | Jun 2011 | - | $-19910.67 | - |
Aug 31, 2010 | Jun 2010 | - | $-10121.20 | - |
Aug 31, 2009 | Jun 2009 | - | $-10131.58 | - |
Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
---|---|---|---|---|
May 16, 2022 | Mar 2022 | - | - | - |
Feb 14, 2022 | Dec 2021 | $27.20M | $23.12M | 0.85% |
Nov 15, 2021 | Sep 2021 | $22.10M | $21.90M | 0.99% |
Sep 27, 2021 | Jun 2021 | $20.90M | $23.48M | 1.12% |
May 17, 2021 | Mar 2021 | $14.06M | $13.48M | 0.96% |
Feb 11, 2021 | Dec 2020 | $12.25M | $15.15M | 1.24% |
Oct 6, 2020 | Sep 2020 | $13.33M | $13.52M | 1.01% |
Sep 24, 2020 | Jun 2020 | $11.24M | $14.86M | 1.32% |
May 15, 2020 | Mar 2020 | $6.40M | $8.16M | 1.27% |
Feb 14, 2020 | Dec 2019 | $2.74M | $3.18M | 1.16% |
Nov 14, 2019 | Sep 2019 | $2.01M | $1.44M | 0.72% |
Sep 26, 2019 | Jun 2019 | $1.77M | $1.72M | 0.97% |
May 14, 2019 | Mar 2019 | $2.03M | $2.38M | 1.17% |
Feb 7, 2019 | Dec 2018 | $1.69M | $1.79M | 1.06% |
Nov 7, 2018 | Sep 2018 | $1.33M | $1.43M | 1.08% |
Sep 6, 2018 | Jun 2018 | $925.00K | $925.00K | 1.00% |
May 14, 2018 | Mar 2018 | $1.25M | $607.00K | 0.49% |
Feb 8, 2018 | Dec 2017 | $1.30M | $1.05M | 0.81% |
Nov 9, 2017 | Sep 2017 | - | $1.08M | - |
Aug 31, 2017 | Jun 2017 | - | $836.00K | - |
May 11, 2017 | Mar 2017 | - | $894.00K | - |
Feb 9, 2017 | Dec 2016 | - | $794.00K | - |
Nov 7, 2016 | Sep 2016 | - | $698.00K | - |
Sep 1, 2016 | Jun 2016 | - | $937.16K | - |
May 4, 2016 | Mar 2016 | - | $668.43K | - |
Dec 31, 2015 | Dec 2015 | - | $469.43K | - |
Sep 30, 2015 | Sep 2015 | - | $487.38K | - |
Mar 31, 2015 | Mar 2015 | - | $23.83K | - |
Feb 28, 2015 | Dec 2014 | - | $29.00K | - |
Nov 30, 2014 | Sep 2014 | - | $27.00K | - |
Aug 31, 2014 | Jun 2014 | - | $1.00K | - |
May 31, 2014 | Mar 2014 | - | $1.00K | - |
Feb 28, 2014 | Dec 2013 | - | - | - |
Nov 30, 2013 | Sep 2013 | - | - | - |
Aug 31, 2013 | Jun 2013 | - | $1.75K | - |
May 31, 2013 | Mar 2013 | - | $1.75K | - |
Feb 28, 2013 | Dec 2012 | - | - | - |
Nov 30, 2012 | Sep 2012 | - | $1.75K | - |
Aug 31, 2012 | Jun 2012 | - | $1.75K | - |
May 31, 2012 | Mar 2012 | - | - | - |
Feb 29, 2012 | Dec 2011 | - | - | - |
Nov 30, 2011 | Sep 2011 | - | - | - |
Aug 31, 2011 | Jun 2011 | - | - | - |
May 31, 2011 | Mar 2011 | - | - | - |
Feb 28, 2011 | Dec 2010 | - | - | - |
Nov 30, 2010 | Sep 2010 | - | - | - |
Aug 31, 2010 | Jun 2010 | - | - | - |
May 31, 2010 | Mar 2010 | - | - | - |
Feb 28, 2010 | Dec 2009 | - | - | - |
Nov 30, 2009 | Sep 2009 | - | - | - |
Aug 31, 2009 | Jun 2009 | - | $1.75K | - |
May 31, 2009 | Mar 2009 | - | $1.75K | - |
Feb 28, 2009 | Dec 2008 | - | - | - |
Nov 30, 2008 | Sep 2008 | - | - | - |
Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
---|---|---|---|---|
Sep 27, 2021 | Jun 2021 | $62.65M | $65.63M | 4.76% |
Sep 24, 2020 | Jun 2020 | $24.02M | $27.63M | 15.04% |
Sep 26, 2019 | Jun 2019 | $7.38M | $7.32M | -0.81% |
Sep 6, 2018 | Jun 2018 | $3.66M | $3.66M | 0.00% |
Aug 31, 2017 | Jun 2017 | - | $3.22M | - |
Sep 1, 2016 | Jun 2016 | - | $2.56M | - |
Aug 31, 2014 | Jun 2014 | - | $58.93K | - |
Aug 31, 2013 | Jun 2013 | - | $1.75K | - |
Aug 31, 2012 | Jun 2012 | - | $1.75K | - |
Aug 31, 2011 | Jun 2011 | - | - | - |
Aug 31, 2010 | Jun 2010 | - | - | - |
Aug 31, 2009 | Jun 2009 | - | $1.75K | - |
AYTU's next earnings date is Monday, Sep 26, 2022 for the fiscal quarter ending Jun 30, 2022.
Aytu Bioscience's previous earnings date was May 16, 2022 for its fiscal quarter ended Mar 31, 2022.
Aytu Bioscience's previous annual earnings date was Sep 27, 2021 for its fiscal year ended Jun 30, 2021.
AYTU's earnings per share (EPS) was $-3.24, missing the consensus analysts forecast of $-2.44 by 32.79% , and higher than the previous year's EPS (Jun 2020) by -35.20%.
Revenues were $65.63M, better than the forecast of $62.65M by 4.76%, and up by 137.52% from previous year's revenue.
The company reported a net income of $-58.29M.
Aytu Bioscience reported a free cash flow of $-25.96M for its fiscal year, compared to $-28.37M a year ago.
The company ended the fiscal year with $28.35M in total debt, an increase of 1025.79% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.